vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Fastly, Inc. (FSLY). Click either name above to swap in a different company.
Fastly, Inc. is the larger business by last-quarter revenue ($172.6M vs $168.4M, roughly 1.0× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 22.8%). Over the past eight quarters, Fastly, Inc.'s revenue compounded faster (13.7% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.
ESPR vs FSLY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $172.6M |
| Net Profit | — | $-15.5M |
| Gross Margin | — | 61.4% |
| Operating Margin | 50.6% | -8.7% |
| Net Margin | — | -9.0% |
| Revenue YoY | 143.7% | 22.8% |
| Net Profit YoY | — | 52.9% |
| EPS (diluted) | $0.32 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $172.6M | ||
| Q3 25 | $87.3M | $158.2M | ||
| Q2 25 | $82.4M | $148.7M | ||
| Q1 25 | $65.0M | $144.5M | ||
| Q4 24 | $69.1M | $140.6M | ||
| Q3 24 | $51.6M | $137.2M | ||
| Q2 24 | $73.8M | $132.4M | ||
| Q1 24 | $137.7M | $133.5M |
| Q4 25 | — | $-15.5M | ||
| Q3 25 | $-31.3M | $-29.5M | ||
| Q2 25 | $-12.7M | $-37.5M | ||
| Q1 25 | $-40.5M | $-39.1M | ||
| Q4 24 | — | $-32.9M | ||
| Q3 24 | $-29.5M | $-38.0M | ||
| Q2 24 | $-61.9M | $-43.7M | ||
| Q1 24 | $61.0M | $-43.4M |
| Q4 25 | — | 61.4% | ||
| Q3 25 | — | 58.4% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 53.2% | ||
| Q4 24 | — | 53.4% | ||
| Q3 24 | — | 54.5% | ||
| Q2 24 | — | 55.1% | ||
| Q1 24 | — | 54.8% |
| Q4 25 | 50.6% | -8.7% | ||
| Q3 25 | -11.4% | -18.2% | ||
| Q2 25 | 8.6% | -24.8% | ||
| Q1 25 | -34.0% | -26.4% | ||
| Q4 24 | -6.4% | -24.4% | ||
| Q3 24 | -31.0% | -29.6% | ||
| Q2 24 | 3.5% | -35.3% | ||
| Q1 24 | 52.5% | -34.6% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | -35.9% | -18.6% | ||
| Q2 25 | -15.4% | -25.2% | ||
| Q1 25 | -62.2% | -27.1% | ||
| Q4 24 | — | -23.4% | ||
| Q3 24 | -57.2% | -27.7% | ||
| Q2 24 | -83.9% | -33.0% | ||
| Q1 24 | 44.3% | -32.5% |
| Q4 25 | $0.32 | $-0.10 | ||
| Q3 25 | $-0.16 | $-0.20 | ||
| Q2 25 | $-0.06 | $-0.26 | ||
| Q1 25 | $-0.21 | $-0.27 | ||
| Q4 24 | $-0.14 | $-0.23 | ||
| Q3 24 | $-0.15 | $-0.27 | ||
| Q2 24 | $-0.33 | $-0.32 | ||
| Q1 24 | $0.34 | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $361.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $929.6M |
| Total Assets | $465.9M | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $361.8M | ||
| Q3 25 | $92.4M | $342.9M | ||
| Q2 25 | $86.1M | $321.2M | ||
| Q1 25 | $114.6M | $307.3M | ||
| Q4 24 | $144.8M | $295.9M | ||
| Q3 24 | $144.7M | $308.2M | ||
| Q2 24 | $189.3M | $311.8M | ||
| Q1 24 | $226.6M | $329.5M |
| Q4 25 | $-302.0M | $929.6M | ||
| Q3 25 | $-451.4M | $937.0M | ||
| Q2 25 | $-433.5M | $942.6M | ||
| Q1 25 | $-426.2M | $957.0M | ||
| Q4 24 | $-388.7M | $965.3M | ||
| Q3 24 | $-370.2M | $969.5M | ||
| Q2 24 | $-344.2M | $981.2M | ||
| Q1 24 | $-294.3M | $991.8M |
| Q4 25 | $465.9M | $1.5B | ||
| Q3 25 | $364.0M | $1.5B | ||
| Q2 25 | $347.1M | $1.5B | ||
| Q1 25 | $324.0M | $1.4B | ||
| Q4 24 | $343.8M | $1.5B | ||
| Q3 24 | $314.1M | $1.5B | ||
| Q2 24 | $352.3M | $1.5B | ||
| Q1 24 | $373.1M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $22.4M |
| Free Cash FlowOCF − Capex | — | $12.2M |
| FCF MarginFCF / Revenue | — | 7.1% |
| Capex IntensityCapex / Revenue | 0.0% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $22.4M | ||
| Q3 25 | $-4.3M | $28.9M | ||
| Q2 25 | $-31.4M | $25.8M | ||
| Q1 25 | $-22.6M | $17.3M | ||
| Q4 24 | $-35.0M | $5.2M | ||
| Q3 24 | $-35.3M | $5.0M | ||
| Q2 24 | $-7.2M | $-4.9M | ||
| Q1 24 | $53.8M | $11.1M |
| Q4 25 | — | $12.2M | ||
| Q3 25 | — | $22.9M | ||
| Q2 25 | — | $15.9M | ||
| Q1 25 | — | $14.7M | ||
| Q4 24 | — | $251.0K | ||
| Q3 24 | $-35.5M | $3.0M | ||
| Q2 24 | $-7.3M | $-6.7M | ||
| Q1 24 | $53.8M | $9.5M |
| Q4 25 | — | 7.1% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | -68.7% | 2.2% | ||
| Q2 24 | -9.9% | -5.1% | ||
| Q1 24 | 39.0% | 7.1% |
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.0% | 3.8% | ||
| Q2 25 | 0.0% | 6.6% | ||
| Q1 25 | 0.0% | 1.8% | ||
| Q4 24 | 0.0% | 3.5% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FSLY
| Network Services | $130.8M | 76% |
| Security | $35.4M | 21% |
| Other | $6.4M | 4% |
